Roivant Sciences Ltd.
ROIV
$36.36
$0.060.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -162.65% | 213.95% | -134.23% | 49.18% | -8.18% |
| Total Depreciation and Amortization | -5.96% | -7.67% | -24.97% | -16.12% | -86.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -136.35% | 125.17% | 174.05% | -245.61% | 729.89% |
| Change in Net Operating Assets | 94.56% | -6,513.54% | 32.47% | 119.04% | -207.78% |
| Cash from Operations | -65.12% | 16.63% | -5.83% | 9.16% | -18.44% |
| Capital Expenditure | 66.77% | -125.55% | 162.88% | -94.50% | -397.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.21% | 71.40% | -18.50% | 111.86% | -208.16% |
| Cash from Investing | 62.12% | 58.48% | -9.09% | 111.09% | -201.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 49.76% | -57.06% | 72.58% | 129.79% | 131.72% |
| Repurchase of Common Stock | -117.75% | -396.99% | -268.09% | 97.02% | 28.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.60% | -- | -- | -- |
| Cash from Financing | -163.91% | -120.96% | 424.38% | 133.33% | -5.99% |
| Foreign Exchange rate Adjustments | -76.06% | 206.05% | -64.34% | 47.98% | 266.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -194.94% | -123.92% | 16,774.26% | 99.90% | -304.02% |